-
Mashup Score: 7An Analysis in NMIBC Patients - A Comparative Study of White Light and Blue Light Cystoscopy in an Equal Access Setting - Stephen B. Williams - 2 month(s) ago
Stephen Williams discusses the evolving role of blue light cystoscopy in detecting non-muscle invasive bladder cancer (NMIBC). The conversation covers its pathophysiology, diagnostic and surveillance applications, emphasizing selective utilization and benefits post-BCG therapy. Dr. Williams references a study in Clinical Genitourinary Cancer, sharing insights from a study comparing blue and…
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3
Ashish Kamat and Morgan Rouprêt explore advancements in non-muscle-invasive bladder cancer (NMIBC) treatments. Professor Rouprêt emphasizes two NMIBC categories: high-grade disease, where muscle-invasive and high-grade bladder cancer lines blur, and low-grade disease, where de-intensification of follow-up and treatment is sought. He highlights the THOR-2 cohort presented by Jim Catto at ESMO,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis - Beyond the Abstract - 2 month(s) ago
non-muscle invasive bladder cancer (NMIBC), transurethral resection of the bladder tumor (TURBT), Tumor T stage, cancer-specific survival (CSS) in patients with non-muscle invasive bladder cancer (NMIBC).
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Navigating NMIBC Risk Stratification and Treatment - Neal Shore - 2 month(s) ago
Ashish Kamat is joined by Neal Shore to delve into risk stratification in non-muscle invasive bladder cancer (NMIBC). Dr. Shore highlights the crucial role of the AUA guidelines, developed with significant contributions from Dr. Kamat and others, in differentiating patients into low, intermediate, and high-risk categories. This stratification informs the frequency of cystoscopies, the intensity…
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet-
Navigating #NMIBC risk stratification and treatment. Neal Shore @CURCMB joins @UroDocAsh @MDAndersonNews to discuss the crucial role of the @AmerUrological guidelines, developed with significant contributions from Dr. Kamat and other leaders in the field > https://t.co/dB8GTF878o https://t.co/ZTPe2rGba6
-
-
Mashup Score: 7An Analysis in NMIBC Patients - A Comparative Study of White Light and Blue Light Cystoscopy in an Equal Access Setting - Stephen B. Williams - 2 month(s) ago
Stephen Williams discusses the evolving role of blue light cystoscopy in detecting non-muscle invasive bladder cancer (NMIBC). The conversation covers its pathophysiology, diagnostic and surveillance applications, emphasizing selective utilization and benefits post-BCG therapy. Dr. Williams references a study in Clinical Genitourinary Cancer, sharing insights from a study comparing blue and…
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 22Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-Unresponsive NMIBC - Stephen Boorjian - 2 month(s) ago
Stephen Boorjian discusses rAd-IFNα (nadofaragene firadenovec), a novel intravesical therapy for BCG-unresponsive non-muscle-invasive bladder cancer. Developed with Dr. Colin Dinney, rAd-IFNα is an adenoviral vector combined with Syn 3, turning the bladder into an interferon bioreactor. The phase three trial showed a 53% complete response rate in patients with carcinoma in situ. Secondary…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7An Analysis in NMIBC Patients - A Comparative Study of White Light and Blue Light Cystoscopy in an Equal Access Setting - Stephen B. Williams - 3 month(s) ago
Stephen Williams discusses the evolving role of blue light cystoscopy in detecting non-muscle invasive bladder cancer (NMIBC). The conversation covers its pathophysiology, diagnostic and surveillance applications, emphasizing selective utilization and benefits post-BCG therapy. Dr. Williams references a study in Clinical Genitourinary Cancer, sharing insights from a study comparing blue and…
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3
Ashish Kamat and Morgan Rouprêt explore advancements in non-muscle-invasive bladder cancer (NMIBC) treatments. Professor Rouprêt emphasizes two NMIBC categories: high-grade disease, where muscle-invasive and high-grade bladder cancer lines blur, and low-grade disease, where de-intensification of follow-up and treatment is sought. He highlights the THOR-2 cohort presented by Jim Catto at ESMO,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Inside the 92nd AUA Meeting: A Deep Dive into High-Risk Non-Muscle Invasive Bladder Cancer - Kriti Mittal - 3 month(s) ago
Kriti Mittal opens a multidisciplinary symposium at the 92nd Meeting of the New England Section of the AUA. The focus of the symposium is on the state-of-the-art management of high-risk non-muscle invasive bladder cancer. Organized in partnership with the Bladder Cancer Advocacy Network and supported by Pfizer, the event features a panel of experts from various institutions. Biographies: Kriti…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Inside the 92nd @AmerUrological meeting: A deep dive into high-risk #NMIBC. Kriti Mittal @UMass introduces the multidisciplinary symposium along with a panel of experts from multiple institutions > https://t.co/sbh2RAF4eR @nsaua @pfizer @BladderCancerUS @DanaFarber @BrighamWomens https://t.co/RAnzymXV4m
-
-
Mashup Score: 4Blue Light Cystoscopy Delays Time To Recurrence in NMIBC Patients Treated in a Real-World Setting - Sia Daneshmand - 3 month(s) ago
Sam Chang and Sia Daneshmand explore the impact of Cysview blue light cystoscopy on cancer recurrence. Dr. Daneshmand presents a comprehensive registry study from USC which shows significantly lower recurrence rates in patients examined with blue light cystoscopy, when compared to a white light patient group. Notwithstanding potential variables like modern management techniques, they attribute…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
An analysis in #NMIBC patients - a comparative study of white light and blue light cystoscopy in an equal access setting. @SWilliams_MD @UTMBUrology joins @zklaassen_md @GACancerCenter in this discussion on UroToday > https://t.co/cTCWQB1LPh @PhotocureASA @Cysview https://t.co/V2QfjhHxGp